Falck delivers strong Q2 results
All Falck’s business areas showed solid progress in Q2 2021. COVID-19 antigen testing in Denmark boosted revenue and earnings significantly. Adjusted for the impact of testing activities, EBITA increased by 56.1%.
President and CEO Jakob Riis said: “Falck has recovered strongly following a year defined by COVID-19. Our Q2 results were lifted significantly by the high number of antigen tests per